FDA/CDC

Portable hematology analyzer gets FDA nod


 

The Food and Drug Administration has granted 510(k) clearance for PixCell Medical’s HemoScreen, a portable hematology analyzer is used to perform a complete blood count at the point of care.

FDA icon

HemoScreen requires a single drop of blood and uses disposable cartridges that provide automatic sample preparation.

HemoScreen can analyze 20 standard complete blood count parameters and produces results within 5 minutes.

Study results suggested that HemoScreen provides results comparable to those of another hematology analyzer, Sysmex XE-2100 (J Clin Pathol. 2016 Aug;69[8]:720-5).

“The HemoScreen delivers lab accurate results,” Avishay Bransky, PhD, CEO of PixCell, said in a statement.

HemoScreen “would be especially useful” in physicians’ offices, emergency rooms, intensive care units, oncology clinics, and remote locations, he added.

HemoScreen makes use of a technology called viscoelastic focusing, which employs microfluidics and machine vision algorithms to analyze cells.

Recommended Reading

Red cell age: No impact on mortality after transfusion
MDedge Family Medicine
Panel votes against universal blood donor screens for Zika virus
MDedge Family Medicine
Zika RNA persists in blood components after clearance from plasma
MDedge Family Medicine
Spray-dried plasma inches toward clinical trials
MDedge Family Medicine
Screening blood donations for Zika proved costly, low yield
MDedge Family Medicine
Blood type A linked to more-severe diarrhea
MDedge Family Medicine
FDA recommends pooled Zika testing of blood donations
MDedge Family Medicine
FDA approves DNA-based blood type test
MDedge Family Medicine
Need blood STAT? Call for a drone
MDedge Family Medicine
Protocol violations, missed transfusions among blood delivery errors
MDedge Family Medicine